Drug & medication recalls Moderate risk

Ascend Laboratories, LLC recalls Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem La…

Recall date
April 27, 2026
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0547-2026
FDA classification
Class II
Brand / firm
Ascend Laboratories, LLC
Sold / distributed
U.S. Nationwide

Why it was recalled

Failed Dissolution Specifications

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* Rx Only, Manufactured by: Alkem Laboratories Ltd., India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-590-01.

Get recall alerts

Free email alert whenever Ascend Laboratories, LLC has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Ascend Laboratories, LLC